Miller Discusses the Use of Selinexor in TP53 Wild-Type Advanced Endometrial Cancer
Season 10, Episode 47, Jul 25, 09:25 PM
Dr Miller discusses findings from the SIENDO trial of selinexor maintenance therapy in patients with TP53 wild-type advanced endometrial cancer.